Binder jetting 3D printing of challenging medicines: From low dose tablets to hydrophobic molecules

The study presents an approach for formulation of 3D printed fast dissolving tablets using binder jetting technology. [Display omitted] Increasing access to additive manufacturing technologies utilising easily available desktop devices opened novel ways for formulation of personalized medicines. It...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmaceutics and biopharmaceutics 2022-01, Vol.170, p.144-159
Hauptverfasser: Kozakiewicz-Latała, Marta, Nartowski, Karol P., Dominik, Aleksandra, Malec, Katarzyna, Gołkowska, Anna M., Złocińska, Adrianna, Rusińska, Małgorzata, Szymczyk-Ziółkowska, Patrycja, Ziółkowski, Grzegorz, Górniak, Agata, Karolewicz, Bożena
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The study presents an approach for formulation of 3D printed fast dissolving tablets using binder jetting technology. [Display omitted] Increasing access to additive manufacturing technologies utilising easily available desktop devices opened novel ways for formulation of personalized medicines. It is, however, challenging to propose a flexible and robust formulation platform which can be used for fabrication of tailored solid dosage forms composed of APIs with different properties (e.g., hydrophobicity) without extensive optimization. This manuscript presents a strategy for formulation of fast dissolving tablets using binder jetting (BJ) technology. The approach is demonstrated using two model APIs: hydrophilic quinapril hydrochloride (QHCl, logP = 1.4) and hydrophobic clotrimazole (CLO, logP = 5.4). The proposed printing method uses inexpensive, well known, and easily available FDA approved pharmaceutical excipients. The obtained model tablets had uniform content of the drug, excellent mechanical properties, and highly porous structure resulting in short disintegration time and fast dissolution rate. The tablets could be scaled and obtained in predesigned shapes and sizes. The proposed method may find its application in the early stages of drug development where high flexibility of the formulation is required and the amount of available API is limited.
ISSN:0939-6411
1873-3441
DOI:10.1016/j.ejpb.2021.11.001